Last Updated: November 16, 2026

Details for Patent: 6,821,987

« Back to Dashboard


Summary for Patent: 6,821,987
Title:Quinoline derivatives and quinazoline derivatives having azolyl group
Abstract:An object of the present invention is to provide compounds having potent antitumor activity. The compounds according to the present invention are compounds represented by formula (I) or pharmaceutically acceptable salts or solvates thereof:wherein X and Z represent CH or N; Y represents O or S; R<1>, R<2>, and R<3 >represent H, alkoxy or the like; R<4 >represents H; R<5>, R<6>, R<7>, and R<8 >represent H, halogen, alkoxy or the like; R<9 >and R<10 >represent H, alkyl or the like; and R<11 >represents optionally substituted azolyl.
Inventor(s):Kazuo Kubo, Teruyuki Sakai, Rika Nagao, Yasunari Fujiwara, Toshiyuki Isoe, Kazumasa Hasegawa
Assignee: KH Neochem Co Ltd , Kyowa Kirin Co Ltd
Application Number:US10/132,473
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,821,987

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,821,987

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2001-132775Apr 27, 2001

International Family Members for US Patent 6,821,987

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1382604 ⤷  Start Trial 300927 Netherlands ⤷  Start Trial
European Patent Office 1382604 ⤷  Start Trial CA 2018 00007 Denmark ⤷  Start Trial
European Patent Office 1382604 ⤷  Start Trial CR 2018 00007 Denmark ⤷  Start Trial
European Patent Office 1382604 ⤷  Start Trial 2018C/008 Belgium ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.